You have searched for "dexamethasone"
Showing 1-10 of 226
WASHINGTON, Nov. 25 (Xinhua) -- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) announced on Wednesday that the fourth iteration of the Adaptive COVID-19 Treatment Trial (ACTT-4) has begun to enroll hospitalized COVID-19 adults who require supplemental oxygen.
(Reuters) - Dr. Drew Miller knew his patient had to be moved.
MOSCOW (Reuters) - Some Russian hospitals are experiencing serious shortages of drugs used to treat COVID-19 and cannot restock because of panic buying, high demand and problems with a new labelling system, officials, distributors and doctors said.
CHICAGO, Nov. 14 (Xinhua) -- A study from Washington University School of Medicine in St. Louis and St. Jude Children's Research Hospital in Memphis, Tennessee, suggests that only 4 percent of COVID-19 patients had the sky-high levels of immune molecules that signify a so-called "cytokine storm."
BRUSSELS (Reuters) - Antiviral remdesivir should not be used as a routine treatment for COVID-19 patients in critical care wards, the head of one of the world's top bodies representing intensive care doctors said, in a blow to the drug developed by U.S. firm Gilead
(Reuters) - The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researchers at the University of Washington’s Institute for Health Metrics and Evaluation (IHME) said on Thursday.
(Reuters) - U.S. infectious disease expert Anthony Fauci said on Thursday that efforts are underway in the U.S. to push for the development of antivirals and other therapies for early intervention during the course of the COVID-19 respiratory illness.
GENEVA, Nov. 9 (Xinhua) -- The resumed session of the 73rd World Health Assembly opened on Monday to address some of the most pressing global health issues and emergencies, including the COVID-19 pandemic that had claimed over 1.25 million lives and infected more than 50 million people worldwide.
BRUSSELS (Reuters) - A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead's